Early Cartilage Degeneration in a Rat Experimental Model of Developmental Dysplasia of the Hip

References

• Stein-Zamir, C., Volovik, I., Rishpon, S., and Sabi, R. (2008). Developmental dysplasia of the hip: Risk markers, clinical screening and outcome. Pediatr. Int. 50(3):341–345.
   PubMed Web of Science ®Google Scholar
• Sharpe, P., Mulpuri, K., Chan, A., and Cundy, P.J. (2006). Differences in risk factors between early and late diagnosed developmental dysplasia of the hip. Arch. Dis. Child Fetal. Neonatal. Ed. 91(3):F158–F162.
   PubMed Web of Science ®Google Scholar
• Yiv, B.C., Saidin, R., Cundy, P.J., Tgetgel, J.D., Aguilar, J., McCaul, K.A., Keane, R.J., Chan, A., and Scott, H. (1997). Developmental dysplasia of the hip in South Australia in 1991: Prevalence and risk factors. J. Paediatr. Child Health 33(2):151–156.
   PubMed Web of Science ®Google Scholar
• Chan, A., McCaul, K.A., Cundy, P.J., Haan, E.A., and Byron-Scott, R. (1997). Perinatal risk factors for developmental dysplasia of the hip. Arch. Dis. Child Fetal. Neonatal. Ed. 76(2):F94–F100.
   PubMed Web of Science ®Google Scholar
• Patel, H. (2001). Preventive health care, 2001 update: Screening and management of developmental dysplasia of the hip in newborns. CMAJ. 164(12):1669–1677.
   PubMed Web of Science ®Google Scholar
• Kutlu, A., Memik, R., Mutlu, M., Kutlu, R., and Arslan, A. (1992). Congenital dislocation of the hip and its relation to swaddling used in Turkey. J. Pediatr. Orthop. 12(5):598–602.
   PubMed Web of Science ®Google Scholar
• Kremli, M.K., Alshahid, A.H., Khoshhal, K.I., and Zamzam, M.M. (2003). The pattern of developmental dysplasia of the hip. Saudi. Med. J. 24(10):1118–1120.
   PubMed Web of Science ®Google Scholar
• Greenhill, B.J., Hainau, B., Ellis, R.D., and el-Sayed, R.M. (1995). Acetabular changes in an experimental model of developmental dysplasia of the hip (DDH). J. Pediatr. Orthop. 15(6):789–793.
   PubMed Web of Science ®Google Scholar
• Zhao, X.M., Wang, E.B., Li, J.J., Zhou, C.F., Zhao, Q., and Zhang, L.J. (2009). Developmental changes of acetabular cartilage complex: An experimental study of a straight-leg swaddle model of newborn rats. Zhongguo Dang Dai Er Ke Za Zhi. 11(10):836–840.
   PubMedGoogle Scholar
• Sijbrandij, S. (1965). Dislocation of the hip in young rats produced experimentally by prolonged extension. J. Bone Joint Surg. Br. 47(4):792–795.
   PubMedGoogle Scholar
• Senaran, H., Ozdemir, H.M., Ogun, T.C., and Kapicioglu, M.I. (2004). Value of limited hip abduction in developmental dysplasia of the hip. Pediatr. Int. 46(4):456–458.
   PubMed Web of Science ®Google Scholar
• Martelpelletier, J., Boileau, C., Pelletier, J., and Roughley, P. (2008). Cartilage in normal and osteoarthritis conditions. Best Pract. Res. Clin. Rheumatol. 22(2):351–384.
   PubMed Web of Science ®Google Scholar
• Brandt, K.D., Dieppe, P., and Radin, E. (2009). Etiopathogenesis of osteoarthritis. Med. Clin. North Am. 93(1):1–24. xv.
   PubMed Web of Science ®Google Scholar
• Wu, Q., Chen, D., Zuscik, M.J., O‘Keefe, R.J., and Rosier, R.N. (2007). Overexpression of Smurf2 stimulates endochondral ossification through upregulation of β-catenin. J. Bone Miner. Res. 23(4):552–563.
   Web of Science ®Google Scholar
• Wang, D., Taboas, J.M., and Tuan, R.S. (2011). PTHrP overexpression partially inhibits a mechanical strain-induced arthritic phenotype in chondrocytes. Osteoarthr. Cartil. 19(2):213–221.
   PubMed Web of Science ®Google Scholar
• Echtermeyer, F., Bertrand, J., Dreier, R., Meinecke, I., Neugebauer, K., Fuerst, M., Lee, Y.J., Song, Y.W., Herzog, C., Theilmeier, G., and Pap, T. (2009). Syndecan-4 regulates ADAMTS-5 activation and cartilage breakdown in osteoarthritis. Nat. Med. 15(9):1072–1076.
   PubMed Web of Science ®Google Scholar
• Plaas, A., Osborn, B., Yoshihara, Y., Bai, Y., Bloom, T., Nelson, F., Mikecz, K., and Sandy, J.D. (2007). Aggrecanolysis in human osteoarthritis: Confocal localization and biochemical characterization of ADAMTS5-hyaluronan complexes in articular cartilages. Osteoarthr. Cartil. 15(7):719–734.
   PubMed Web of Science ®Google Scholar
• Li, J., Anemaet, W., Diaz, M.A., Buchanan, S., Tortorella, M., Malfait, A.M., Mikecz, K., Sandy, J.D., and Plaas, A. (2010). Knockout of ADAMTS5 does not eliminate cartilage aggrecanase activity but abrogates joint fibrosis and promotes cartilage aggrecan deposition in murine osteoarthritis models. J. Orthop. Res. 29(4):51–522.
   Google Scholar
• Chang, J.K., Chang, L.H., Hung, S.H., Wu, S.C., Lee, H.Y., Lin, Y.S., Chen, C.H., Fu, Y.C., Wang, G.J., and Ho, M.L. (2009). Parathyroid hormone 1–34 inhibits terminal differentiation of human articular chondrocytes and osteoarthritis progression in rats. Arthritis Rheum. 60(10):3049–3060.
   PubMed Web of Science ®Google Scholar
• Wang, X., Manner, P.A., Horner, A., Shum, L., Tuan, R.S., and Nuckolls, G.H. (2004). Regulation of MMP-13 expression by RUNX2 and FGF2 in osteoarthritic cartilage. Osteoarthr. Cartil. 12(12):963–973.
   PubMed Web of Science ®Google Scholar
• Dudkiewicz, I., Salai, M., Ganel, A., Blankstein, A., and Chechik, A. (2002). Total hip arthroplasty in patients younger than 30 years of age following developmental dysplasia of hip (DDH) in infancy. Arch. Orthop. Trauma. Surg. 122(3):139–142.
   PubMed Web of Science ®Google Scholar
• Thomas, S.R., Wedge, J.H., and Salter, R.B. (2007). Outcome at forty-five years after open reduction and innominate osteotomy for late-presenting developmental dislocation of the hip. J. Bone Joint Surg. Am. 89(11):2341–2350.
   PubMedGoogle Scholar
• Mankin, H.J., Johnson, M.E., and Lippiello, L. (1981). Biochemical and metabolic abnormalities in articular cartilage from osteoarthritic human hips. III. Distribution and metabolism of amino sugar-containing macromolecules. J. Bone Joint Surg. Am. 63(1):131–139.
   PubMed Web of Science ®Google Scholar
• Mavcic, B., Iglic, A., Kralj-Iglic, V., Brand, R.A., and Vengust, R. (2008). Cumulative hip contact stress predicts osteoarthritis in DDH. Clin. Orthop. Relat. Res. 466(4):884–891.
   PubMed Web of Science ®Google Scholar
• Wu, Q., Kim, K.-O., Sampson, E.R., Chen, D., Awad, H., O‘Brien, T., Puzas, J.E., Drissi, H., Schwarz, E.M., O‘Keefe, R.J., Zuscik, M.J., and Rosier, R.N. (2008). Induction of an osteoarthritis-like phenotype and degradation of phosphorylated Smad3 by Smurf2 in transgenic mice. Arthritis Rheum. 58(10):3132–3144.
   PubMed Web of Science ®Google Scholar
• Sun, H.B. (2010). Mechanical loading, cartilage degradation, and arthritis. Ann. N. Y. Acad. Sci. 1211(1):37–50.
   PubMed Web of Science ®Google Scholar
• da Silva, M.A., Yamada, N., Clarke, N.M., and Roach, H.I. (2009). Cellular and epigenetic features of a young healthy and a young osteoarthritic cartilage compared with aged control and OA cartilage. J. Orthop. Res. 27(5):593–601.
   PubMed Web of Science ®Google Scholar
• Wu, Q., Huang, J.H., Sampson, E.R., Kim K-O, K., Zuscik, M.J., O‘Keefe, R.J., Chen, D., and Rosier, R.N. (2009). Smurf2 induces degradation of GSK-3β and upregulates β-catenin in chondrocytes: A potential mechanism for Smurf2-induced degeneration of articular cartilage. Exp. Cell Res. 315(14):2386–2398.
   PubMed Web of Science ®Google Scholar
• Burdan, F., Szumiło, J., Korobowicz, A., Farooquee, R., Patel, S., Patel, A., Dave, A., Szumiło, M., Solecki, M., Klepacz, R., and Dudka, J. (2009). Morphology and physiology of the epiphyseal growth plate. Folia Histochem. Cytobiol. 47(1):5–16.
   PubMed Web of Science ®Google Scholar
• Goldring, M.B., and Goldring, S.R. (2007). Osteoarthritis. J. Cell. Physiol. 213(3):626–634.
   PubMed Web of Science ®Google Scholar
• Boileau, C., Martel-Pelletier, J., Fahmi, H., Mineau, F., Boily, M., and Pelletier, J.-P. (2007). The peroxisome proliferator–activated receptor γ agonist pioglitazone reduces the development of cartilage lesions in an experimental dog model of osteoarthritis: In vivo protective effects mediated through the inhibition of key signaling and catabolic pathways. Arthritis Rheum. 56(7):2288–2298.
   PubMed Web of Science ®Google Scholar
• Moldovan, F., Pelletier, J.P., Hambor, J., Cloutier, J.M., and Collagenase, M.-P.J. (1997). 3 (matrix metalloprotease 13) is preferentially localized in the deep layer of human arthritic cartilage in situ: In vitro mimicking effect by transforming growth factor beta. Arthritis Rheum. 40(9):1653–1661.
   PubMed Web of Science ®Google Scholar
• Stanton, H., Rogerson, F.M., East, C.J., Golub, S.B., Lawlor, K.E., Meeker, C.T., Little, C.B., Last, K., Farmer, P.J., Campbell, I.K., Fourie, A.M., and Fosang, A.J. (2005). ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro. Nature 434(7033):648–652.
   PubMed Web of Science ®Google Scholar
• Malfait, A.M., Ritchie, J., Gil, A.S., Austin, J.S., Hartke, J., Qin, W., Tortorella, M.D., and Mogil, J.S. (2010). ADAMTS-5 deficient mice do not develop mechanical allodynia associated with osteoarthritis following medial meniscal destabilization. Osteoarthr. Cartil. 18(4):572–580.
   PubMed Web of Science ®Google Scholar
• Glasson, S.S., Askew, R., Sheppard, B., Carito, B., Blanchet, T., Ma, H.L., Flannery, C.R., Peluso, D., Kanki, K., Yang, Z., Majumdar, M.K., and Morris, E.A. (2005). Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis. Nature 434(7033):644–648.
   PubMed Web of Science ®Google Scholar
• Rogerson, F.M., Stanton, H., East, C.J., Golub, S.B., Tutolo, L., Farmer, P.J., and Fosang, A.J. (2008). Evidence of a novel aggrecan-degrading activity in cartilage: Studies of mice deficient in both ADAMTS-4 and ADAMTS-5. Arthritis Rheum. 58(6):1664–1673.
   PubMed Web of Science ®Google Scholar
• Meyer, R.A., Jr., Meyer, M.H., Ashraf, N., and Frick, S. (2007). Changes in mRNA gene expression during growth in the femoral head of the young rat. Bone. 40(6):1554–1564.
   PubMed Web of Science ®Google Scholar
• Goldring, M.B., and Goldring, S.R. (2007). Osteoarthritis. J. Cell. Physiol. 213(3):626–634.
   PubMed Web of Science ®Google Scholar
• Boileau, C., Martel-Pelletier, J., Fahmi, H., Mineau, F., Boily, M., and Pelletier, J.-P. (2007). The peroxisome proliferator–activated receptor γ agonist pioglitazone reduces the development of cartilage lesions in an experimental dog model of osteoarthritis: In vivo protective effects mediated through the inhibition of key signaling and catabolic pathways. Arthritis & Rheumatism. 56(7):2288–2298.
   PubMed Web of Science ®Google Scholar
• Orlandi, A., Oliva, F., Taurisano, G., Candi, E., Di Lascio, A., Melino, G., Spagnoli, L.G., and Tarantino, U. (2008). Transglutaminase-2 differently regulates cartilage destruction and osteophyte formation in a surgical model of osteoarthritis. Amino Acids. 36(4):755–763.
   PubMed Web of Science ®Google Scholar